Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Nivolumab and Ipilimumab in Mucinous Colorectal and Appendiceal Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03693846
Recruitment Status : Recruiting
First Posted : October 3, 2018
Last Update Posted : April 16, 2019
Sponsor:
Information provided by (Responsible Party):
Abramson Cancer Center of the University of Pennsylvania

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : November 2020
  Estimated Study Completion Date : November 2023